Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy

Jaiswal V, Hanif M, Mashkoor Y, Prasad T, Fonarow GC. Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy. JACC Adv. 2025 Apr 14;4(5):101696. doi: 10.1016/j.jacadv.2025.101696. Epub ahead of print. PMID: 40286362.


Related Posts